Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan.

Схожие документы

• Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors.
  по: Schambye, H T, et al.
  Опубликовано: (1994)
• Experimental Aortic Intimal Thickening: II. Endothelialization and Permeability
  по: Webster, W. S., et al.
  Опубликовано: (1974)
• Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
  по: Ohtawa, M, et al.
  Опубликовано: (1993)
• Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
  по: Wienen, W., et al.
  Опубликовано: (1993)
• Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
  по: Criscione, L., et al.
  Опубликовано: (1993)